PT3210018T - Métodos e composições para o diagnóstico e prognóstico de lesão renal e insuficiência renal - Google Patents

Métodos e composições para o diagnóstico e prognóstico de lesão renal e insuficiência renal

Info

Publication number
PT3210018T
PT3210018T PT15853584T PT15853584T PT3210018T PT 3210018 T PT3210018 T PT 3210018T PT 15853584 T PT15853584 T PT 15853584T PT 15853584 T PT15853584 T PT 15853584T PT 3210018 T PT3210018 T PT 3210018T
Authority
PT
Portugal
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
PT15853584T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of PT3210018T publication Critical patent/PT3210018T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PT15853584T 2014-10-20 2015-10-20 Métodos e composições para o diagnóstico e prognóstico de lesão renal e insuficiência renal PT3210018T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462066316P 2014-10-20 2014-10-20
US201462066313P 2014-10-20 2014-10-20
US201462066310P 2014-10-20 2014-10-20

Publications (1)

Publication Number Publication Date
PT3210018T true PT3210018T (pt) 2021-10-04

Family

ID=55761743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15853584T PT3210018T (pt) 2014-10-20 2015-10-20 Métodos e composições para o diagnóstico e prognóstico de lesão renal e insuficiência renal

Country Status (13)

Country Link
US (2) US11333671B2 (cg-RX-API-DMAC10.html)
EP (2) EP3210018B1 (cg-RX-API-DMAC10.html)
JP (4) JP6792553B2 (cg-RX-API-DMAC10.html)
KR (1) KR102431003B1 (cg-RX-API-DMAC10.html)
CN (2) CN107003301B (cg-RX-API-DMAC10.html)
AU (2) AU2015336069B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017008218A2 (cg-RX-API-DMAC10.html)
CA (1) CA2965153C (cg-RX-API-DMAC10.html)
EA (1) EA201790696A1 (cg-RX-API-DMAC10.html)
ES (1) ES2907551T3 (cg-RX-API-DMAC10.html)
MX (1) MX388231B (cg-RX-API-DMAC10.html)
PT (1) PT3210018T (cg-RX-API-DMAC10.html)
WO (1) WO2016064877A2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201790696A1 (ru) 2014-10-20 2017-10-31 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
US11353465B2 (en) 2017-01-12 2022-06-07 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2019133902A2 (en) 2017-12-28 2019-07-04 Astute Medical, Inc. Antibodies and assays for ccl14
CA3094993A1 (en) * 2018-04-02 2019-10-10 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
US12114978B2 (en) 2018-04-02 2024-10-15 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
CN114207436A (zh) * 2019-05-24 2022-03-18 机敏医药股份有限公司 基于c-c基序趋化因子配体14测量而评估和治疗肾损伤的方法
US20230290457A1 (en) * 2020-03-23 2023-09-14 Biocogniv Inc. Artificial intelligence medical device
GB2596142B (en) * 2020-06-19 2023-11-29 Secr Defence Methods and associated uses, kits and systems for assessing sepsis
AU2021381364A1 (en) * 2020-11-18 2023-06-22 Astute Medical, Inc. Methods and compositions for treatment of renal injury and renal failure
JP7902180B2 (ja) * 2020-12-16 2026-08-07 ジュノー セラピューティクス インコーポレイテッド フローサイトメトリー方法のための閾値ゲーティング
EP4487114A4 (en) * 2022-03-03 2026-03-25 Astute Medical Inc METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING PERSISTENT ACUTE RENAL INJURY BASED ON A C-C MOTIFYING CHEMOKIN LIGAND MEASUREMENT 14
JP2024039982A (ja) * 2022-09-12 2024-03-25 栄研化学株式会社 急性腎障害の発症リスクの評価方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
AU1772992A (en) 1991-04-10 1992-11-17 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
AU2003223172A1 (en) 2002-02-12 2003-09-04 Quark Biotech, Inc. Use of the axl receptor for diagnosis and treatment of renal disease
US20120064089A1 (en) * 2002-11-15 2012-03-15 Morehouse School Of Medicine Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
WO2007013919A2 (en) 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
JP2009508650A (ja) * 2005-09-21 2009-03-05 ダスク テクノロジーズ, エルエルシー 臓器および組織機能のための方法および組成
US20110059537A1 (en) 2007-09-20 2011-03-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
US20090226435A1 (en) * 2008-03-08 2009-09-10 Sanjay Khare Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
EP2767833A3 (en) * 2008-10-21 2014-12-17 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011017685A1 (en) 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney transplant rejection
CA2774223A1 (en) 2009-09-21 2011-03-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290195A1 (ru) * 2009-11-07 2012-12-28 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX340078B (es) * 2009-11-07 2016-06-24 Astute Medical Inc Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal.
US20120156701A1 (en) * 2009-12-20 2012-06-21 Joseph Anderberg Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX342967B (es) 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
CN102791885B (zh) * 2010-02-05 2015-09-09 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
NZ605698A (en) * 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (cg-RX-API-DMAC10.html) * 2010-06-23 2015-05-22 Astute Medical Inc
CN105137085A (zh) * 2010-06-23 2015-12-09 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
WO2012136548A1 (en) 2011-04-04 2012-10-11 Universiteit Gent Biomarkers for acute kidney injury
CA2846602A1 (en) * 2011-08-26 2013-03-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
EP2962109A4 (en) 2013-02-26 2016-12-07 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
EA201790696A1 (ru) 2014-10-20 2017-10-31 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности

Also Published As

Publication number Publication date
WO2016064877A2 (en) 2016-04-28
CN110702921A (zh) 2020-01-17
JP2023052587A (ja) 2023-04-11
CA2965153C (en) 2023-10-24
JP2021039112A (ja) 2021-03-11
US11333671B2 (en) 2022-05-17
EA201790696A1 (ru) 2017-10-31
EP3210018A4 (en) 2018-06-20
US20220236286A1 (en) 2022-07-28
JP6792553B2 (ja) 2020-11-25
MX388231B (es) 2025-03-19
KR102431003B1 (ko) 2022-08-09
JP7002623B2 (ja) 2022-02-10
AU2015336069B2 (en) 2021-11-25
EP3968022A1 (en) 2022-03-16
AU2015336069A1 (en) 2017-05-25
AU2022201130B2 (en) 2024-06-27
ES2907551T3 (es) 2022-04-25
KR20170084102A (ko) 2017-07-19
US20180209990A1 (en) 2018-07-26
CN107003301B (zh) 2019-11-01
EP3210018A2 (en) 2017-08-30
WO2016064877A3 (en) 2016-09-09
US12099067B2 (en) 2024-09-24
CN107003301A (zh) 2017-08-01
EP3210018B1 (en) 2021-07-28
JP2022046669A (ja) 2022-03-23
CA2965153A1 (en) 2016-04-28
JP2017533427A (ja) 2017-11-09
CN110702921B (zh) 2024-02-06
JP7217796B2 (ja) 2023-02-03
BR112017008218A2 (pt) 2018-01-09
MX2017005126A (es) 2017-09-15
AU2022201130A1 (en) 2022-03-17

Similar Documents

Publication Publication Date Title
PL2946211T3 (pl) Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia oraz niewydolności nerek
IL276516A (en) Methods for diagnosing and treating inflammatory bowel disease
EP3210018A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3077819A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IL248837A0 (en) Methods and preparations for the treatment of autoimmune and inflammatory conditions
IL249968B (en) Preparation of a test site
GB201708360D0 (en) Methods for determining health risks
EP3004873A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3281011A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DK3209673T3 (en) Mixtures of HMOs
EP3577458A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF RENAL LESION AND RENAL INSUFFICIENCY
ZA201607571B (en) Compositions and methods for detecting huanglongbing
HRP20181265T1 (hr) Mif inhibitori
SG10201404895XA (en) Diagnosis
EP3092027A4 (en) Transpapillary methods and compositions for diagnosing and treating breast conditions
GB201700439D0 (en) Methods for assessing vaginal atrophy
GB201520365D0 (en) Early entry
GB2544635B (en) Monitoring of lined pipeline
EP2962109A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
EP3218724A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
GB201409851D0 (en) Diagnostic method
EP2820146A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF KIDNEY LUNGION AND KIDNEY INSUFFICIENCY
EP2880442A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
GB201509658D0 (en) Method of diagnosis
EP3233106A4 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure